Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|December 6, 2019
Using Didactics and Simulation to Enhance Comfort, Knowledge, and Skills of Nonsurgical Trainees Caring for Patients With Tracheostomy and LaryngectomyKevin Allen Davis, Courtney L Edgar-Zarate, Juliana Bonilla-Velez, et al.
Transplantation|January 13, 2009
Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in ratsShaheed Merani, Rena L Pawlick, Ryan L Edgar, et al.
AJNR. American Journal of Neuroradiology|April 30, 2021
The Updated Neuroradiology Milestones: Synapsing from 1.0 to 2.0A A Bhatt, R M Kurtz, T A Kennedy, et al.
The New Zealand Medical Journal|May 11, 2001
Interferon-alpha2a/ribaviran versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferonB A Chapman, N H Stace, C L Edgar, et al.
Surgery|September 28, 2011
Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse modelAllison H Maciver, Michael D McCall, Ryan L Edgar, et al.
Islets|September 22, 2011
AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro, nor after transplantation into immunodeficient miceShaheed Merani, Michael McCall, Rena L Pawlick, et al.
Organic & Biomolecular Chemistry|November 7, 2019
Expedient synthesis of highly substituted 3,4-dihydro-1,2-oxathiine 2,2-dioxides and 1,2-oxathiine 2,2-dioxides: revisiting sulfene additions to enaminoketonesStuart Aiken, Kelechi Anozie, Orlando D C C de Azevedo, et al.
Nature Communications|March 8, 2020
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myelomaRicha Bajpai, Aditi Sharma, Abhinav Achreja, et al.
Science Advances|September 28, 2022
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myelomaAditi Sharma, Remya Nair, Abhinav Achreja, et al.
Blood|January 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicityChristopher Ronald Funk, Shuhua Wang, Kevin Z Chen, et al.
Pageof 17